about
In silico Mechano-Chemical Model of Bone Healing for the Regeneration of Critical Defects: The Effect of BMP-2Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system.Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation.Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects.Improved bone morphogenetic protein-2 retention in an injectable collagen matrix using bifunctional peptides.The Axolotl Fibula as a Model for the Induction of Regeneration across Large Segment Defects in Long Bones of the ExtremitiesCharacterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration.Growth factor delivery for bone tissue repair: an update.Tissue engineering in musculoskeletal problems related to haemophilia.Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivoNovel microhydroxyapatite particles in a collagen scaffold: a bioactive bone void filler?Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds.The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres.Characterization of recombinant human bone morphogenetic protein-2 delivery from injectable hyaluronan-based hydrogels by means of 125I-radiolabelling.The meniscal healing process.Sinus augmentation using rhBMP-2-loaded synthetic bone substitute with simultaneous implant placement in rabbits.Comparative analysis of carrier systems for delivering bone morphogenetic proteinsA differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model.Effects of protein dose and delivery system on BMP-mediated bone regeneration.Clinical application of recombinant human bone morphogenetic protein-2 in 4 dogs.Use of a collagen membrane loaded with recombinant human bone morphogenetic protein-2 with collagen-binding domain for vertical guided bone regeneration.Sinus augmentation using BMP-2 in a bovine hydroxyapatite/collagen carrier in dogs.Effects of rhBMP-2 Loaded Titanium Reinforced Collagen Membranes on Horizontal Bone Augmentation in Dogs.The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects.Mandibular reconstruction of a partial hemimandibulectomy in a dog with severe malocclusion.Primary ridge augmentation with collagenated xenogenic block bone substitute in combination with collagen membrane and rhBMP-2: a pilot histological investigation.Implant-guided supracrestal alveolar bone growth using scaffolds, BMP-2, and novel scaffold-retaining device.Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects.Initial Experience With rhBMP-2 Delivered in a Compressive Resistant Matrix for Mandibular Reconstruction in 5 Dogs.Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2.
P2860
Q28547838-D4298DDA-52E6-4C28-BF92-700605640196Q33605581-C9C4C1D8-18B3-4F26-AE7B-BF35A32EFAC0Q34145493-8001A6C0-ADCD-43AD-8E25-AE083B138EEDQ34160953-D1169542-7A35-4366-97E2-3514F841F3E6Q34947536-5932721A-BE9F-4DFE-A539-B33DC133896DQ35670745-E89BF164-43BE-4827-BA53-89B24C89180CQ35765486-030BCE2C-86CC-4278-B33F-312594496AE3Q36316612-BE78B9A3-930F-43C4-9DB4-7498CA314658Q36473086-4846291D-FF63-4036-A1CD-62F2C1B48E26Q36772921-9B796864-D290-41F0-ADCC-021E121DF5A2Q36961185-FE3CC7E1-4474-4C16-9577-0D14F3E675B0Q37109219-DEBD5CC5-D9E1-4BC8-9D48-E8935D4B1D23Q37614319-CBAF5607-69D0-413E-B713-279348678CE9Q37693763-6AACDB6C-9A17-4F3B-8363-8388AA08F74CQ38759581-99B83C17-289B-4AB8-8769-A392EA8DB675Q39234885-F4865E56-06E8-4338-9B93-59F5B7E80F3DQ39289837-F050DF65-538E-480D-9E97-F9924D0345B9Q41145332-D441E42F-252F-4460-B447-976C4D5C747BQ42002739-A33B3D0D-96EA-441E-857D-696D66A883DAQ42093221-DD822F2F-581E-498C-921F-7D9B3F7E141DQ42532319-58D7C46E-1B3B-4560-898E-9160447FA37BQ42787240-706F3D53-5146-4473-99D7-ED29C25B66F1Q43715084-1C59DED4-A44F-4553-9C57-ACBCE0A91D62Q44211423-335B6CF6-2E12-466B-81B6-E1EBE26FCC57Q46269237-E0F415C1-C785-4ACA-8385-48E8626ACD47Q47111316-C3A170AA-D413-4964-BFBE-ACE00485B2FEQ47339032-14584A3B-6412-430A-BC42-A3B9D4482C2FQ47933427-05B95296-E32B-43EB-A4A2-D3D0E6E88FC8Q48336952-8B26C771-ED01-4E4F-86C1-C4787FE4153DQ50968494-19D42AC3-06C2-492C-BC73-18F58FD012D9Q51308848-CACF550D-F89A-4D7E-9CBF-018D8E36E331Q53601370-8761352E-C812-488C-B7E0-5BA36EAAAA03Q53624920-D4980053-8320-4F40-845F-F619FD67032A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Bone morphogenetic protein delivery systems.
@ast
Bone morphogenetic protein delivery systems.
@en
Bone morphogenetic protein delivery systems.
@nl
type
label
Bone morphogenetic protein delivery systems.
@ast
Bone morphogenetic protein delivery systems.
@en
Bone morphogenetic protein delivery systems.
@nl
prefLabel
Bone morphogenetic protein delivery systems.
@ast
Bone morphogenetic protein delivery systems.
@en
Bone morphogenetic protein delivery systems.
@nl
P2093
P1433
P1476
Bone morphogenetic protein delivery systems.
@en
P2093
Howard Seeherman
John Wozney
Rebecca Li
P304
P356
10.1097/00007632-200208151-00005
P407
P433
16 Suppl 1
P577
2002-08-01T00:00:00Z